MA56108A - Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments - Google Patents

Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments

Info

Publication number
MA56108A
MA56108A MA056108A MA56108A MA56108A MA 56108 A MA56108 A MA 56108A MA 056108 A MA056108 A MA 056108A MA 56108 A MA56108 A MA 56108A MA 56108 A MA56108 A MA 56108A
Authority
MA
Morocco
Prior art keywords
plant
precursor
supplements
foods
drugs
Prior art date
Application number
MA056108A
Other languages
English (en)
Inventor
Peter Bos
Giorgio Stefano Cerana
Original Assignee
Vivatis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivatis Pharma Gmbh filed Critical Vivatis Pharma Gmbh
Publication of MA56108A publication Critical patent/MA56108A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Sustainable Development (AREA)
MA056108A 2019-06-07 2020-06-08 Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments MA56108A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000008409A IT201900008409A1 (it) 2019-06-07 2019-06-07 Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci

Publications (1)

Publication Number Publication Date
MA56108A true MA56108A (fr) 2022-04-13

Family

ID=68281820

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056108A MA56108A (fr) 2019-06-07 2020-06-08 Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments

Country Status (15)

Country Link
US (1) US20220304355A1 (fr)
EP (1) EP3980030A2 (fr)
JP (1) JP2022535453A (fr)
KR (1) KR20220019275A (fr)
CN (1) CN114174349A (fr)
AU (1) AU2020287013A1 (fr)
BR (1) BR112021024063A2 (fr)
CA (1) CA3142672A1 (fr)
EA (1) EA202193158A1 (fr)
IL (1) IL288629A (fr)
IT (1) IT201900008409A1 (fr)
MA (1) MA56108A (fr)
MX (1) MX2021014736A (fr)
WO (1) WO2020245809A2 (fr)
ZA (1) ZA202109499B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000013633A1 (it) * 2020-06-08 2021-12-08 Vivatis Pharma Gmbh Processo di estrazione di una condroitina solfato da un fungo, una condroitina solfato di origine vegetale e suo uso
AU2021286956A1 (en) * 2020-06-08 2023-01-05 Vivatis Pharma Gmbh Process for extracting a hyaluronic acid from a fungus, a hyaluronic acid of plant origin and use thereof
IT202000013618A1 (it) * 2020-06-08 2021-12-08 Vivatis Pharma Gmbh Processo di estrazione di un acido ialuronico da un fungo, un acido ialuronico di origine vegetale e suo uso
IT202000022471A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202200015375A1 (it) 2022-07-21 2024-01-21 Vivatis Pharma Italia S R L Un nuovo acido ialuronico ad alto peso molecolare o un suo sale di origine vegetale per l’uso nel mantenere l'omeostasi articolare e prevenire i processi dannosi dell'osteoartrite

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291394B1 (it) * 1997-01-10 1999-01-11 Innovet Italia Composizioni ad attivita' condroprotettiva per il trattamento di artropatie traumatiche e/o cronico-degenerative.
TWI398275B (zh) * 2010-07-12 2013-06-11 Agricultural Res Inst 皮膚創傷敷料及其製備方法
RS53135B (en) * 2011-11-24 2014-06-30 Quimera Ingenieria Biomedica, S.L. COMPLEX OBTAINED FROM HYALURONIC ACID OR ITS SALT AND MIXTURE OF HONDROITIN SULPHATE
CN104140472B (zh) * 2013-05-08 2017-11-28 清华大学 精品硫酸软骨素a和c和制备精品硫酸软骨素a和c的方法
EP3463304A4 (fr) * 2016-05-24 2020-01-08 Bol Pharma Ltd. Compositions comprenant du cannabidiol et de l'acide hyaluronique pour le traitement de maladies inflammatoires des articulations
CN105950688A (zh) * 2016-06-25 2016-09-21 仇颖超 一种以银耳子实体制备植物基透明质酸的方法
CN106074214A (zh) * 2016-07-13 2016-11-09 袁春华 一种抗辐射防衰老面膜的制备方法
IT201600101413A1 (it) * 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
CN106905440B (zh) * 2017-04-14 2019-03-19 中国林业科学研究院林产化学工业研究所 一种银耳多糖提取的方法
CN107522782A (zh) * 2017-09-26 2017-12-29 天津市天大天福生物技术有限公司 一种梯度胶原蛋白及胶原多肽分子的制备方法及其应用
IT201700124434A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.
CN109430650A (zh) * 2018-11-22 2019-03-08 天津市天大天福生物技术有限公司 制备胶原蛋白、透明质酸饮料和滋补液的配方与生产工艺

Also Published As

Publication number Publication date
MX2021014736A (es) 2022-02-11
IT201900008409A1 (it) 2020-12-07
AU2020287013A1 (en) 2021-12-23
WO2020245809A3 (fr) 2021-01-14
KR20220019275A (ko) 2022-02-16
JP2022535453A (ja) 2022-08-08
US20220304355A1 (en) 2022-09-29
BR112021024063A2 (pt) 2022-04-26
WO2020245809A2 (fr) 2020-12-10
EP3980030A2 (fr) 2022-04-13
IL288629A (en) 2022-02-01
WO2020245809A4 (fr) 2021-04-08
ZA202109499B (en) 2024-05-30
EA202193158A1 (ru) 2022-03-17
CA3142672A1 (fr) 2020-12-10
CN114174349A (zh) 2022-03-11

Similar Documents

Publication Publication Date Title
MA56108A (fr) Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments
US20180000095A1 (en) Microbicidal oil-in-water dispersion
BR112019006957A2 (pt) uso de idhp na preparação de fármaco ou produto de saúde para a prevenção e tratamento de doença de aterosclerose coronária
US20220009882A1 (en) Organosulfur compounds
CR20220620A (es) Composición farmacéutica acuosa de levilimab y su uso
CN1647802A (zh) 一种皮肤外用品
CN1170528A (zh) 一种藻制品
CN217067144U (zh) 一种病媒生物防制用药剂喷洒装置
Vons et al. Comparative study of markets of Ukraine, Poland and Russia on registered medications for local treatment of burns
CN103893665B (zh) 一种提高鸡产蛋量的中药组合物
Tikhonov et al. Problem aspects of the new technologies ophthalmic drugs
Кузякова et al. THE MAIN TRENDS IN THE DEVELOPMENT OF THE PHARMACEUTICAL MARKET
Shpychak et al. Marketing research of the pharmaceutical market of medicines used topically for diseases of the locomotor apparatus
Seryogin et al. About illness of foodborne diseases
Matiacevich Development of bioactive/active additives based on essential oils: A review
Pinkevych et al. Lichens are sources of biological active compounds
JP6749563B2 (ja) 黄色ブドウ球菌抑制溶液、アトピー性皮膚炎治療液、化粧品、洗浄液及び消毒液
CN106606632A (zh) 一种嘴唇干裂抑菌护理膏
Кунанбай et al. Modern principles of pharmacotherapy in Neonatology
CN109833388A (zh) 一种口腔溃疡灵
CN102283825A (zh) 一种具有广普杀菌的药物
Lisovska et al. The relevance of creating a homeopathic anti-inflammatory drug
MacDonald Medicinal Plants and Tomorrow’s Pharmacy–Nigerian Experience
CLEANSERS hexachlorophene (C) dispense 5 ml into wet hand, work up into lather; then apply to area to be cleansed; rinse thoroughly pHisoHex Liq clnsr: 5, 16 oz
CN1923267A (zh) 一种妇科外用抗菌药物及其制备方法